Tumor contact surface area is associated with volume loss and functional decline after partial nephrectomy  by Wang, Yu-De et al.
Abstracts / Urological Science 27 (2016) S24eS35 S25was higher in patients without preoperative proteinuria (76% vs. 94%,
P¼0.0027).
Conclusion: Preoperative proteinuria could help stratify patients accord-
ing to the risk of renal function exacerbation.
IPD04:
TUMOR CONTACT SURFACE AREA IS ASSOCIATED WITH VOLUME LOSS
AND FUNCTIONAL DECLINE AFTER PARTIAL NEPHRECTOMY
Yu-De Wang, Chao-Hsiang Chang, Chi-Ping Huang, Hsi-Chin Wu, Che-Rei
Yang, Guang-Heng Chen, Po-Fan Hsieh. Department of Urology, China
Medical University Hospital, Taichung, Taiwan
Purpose: We propose a formula of calculate-based contact surface area
(CSA). We examined the correlation of contact surface area and renal
volume loss and the predictability for renal function after partial
nephrectomy.
Materials and Methods: We conducted a retrospective study in patients
who underwent partial nephrectomy between January 2012 and
December 2014. Based on abdominopelvic CT and MRI, we calculated the
contact surface areawith the formula “2* p *Radius*Depth”; while resected
and ischemic volume (RAIV) was determined by the equation”
[2w^2+3w(r+d)+6rd]*w*p)/3”. We evaluated the correlation between CSA,
RAIV and perioperative parameters. And we comparatively analyzed the
ability of CSA and RAIV to predict the reduction in renal function.
Results: There were 35, 26, and 45 patients receiving OPN, LPN, RPN
respectively. The mean±SD contact surface area was 30.7±26.1 cm2, and
and the mean±SD RAIV was 19.1±14.4 cm3. On Spearman correlation
analysis we found that CSA and RAIV were highly correlated (coefﬁcient:
0.99, p<0.001). In univariate analysis, BMI (p¼0.02), EBL (p¼0.001), RAIV
(p<0.001), and CSA (p<0.001) signiﬁcantly affected postoperative renal
function. In ROC curve analysis, both CSA and RAIV have good ability to
predict more than 10% change of estimated glomerular ﬁltration rate (AUC:
0.86 vs. 0.87). There is no signiﬁcant difference in AUC between CSA and
RAIV. The area difference in PCE10 was 0.002 (p¼0.51)
Conclusion: In our study, CSA and RAIV were correlated with several
perioperative outcomes and affected post-operative renal function. The
ability to predict post-operative renal function between CSA and RAIV was
nearly identical. Since CSA was simpler to use, and may possess less
interobserver variability in comparisonwith RAIV, we believe that CSA can
represent renal parenchymal loss.
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IPD05:
CHARACTERISTICS OF EARLY-ONSET HEMATOTOXICITY OF SUNITINIB
IN JAPANESE PATIENTS WITH RENAL CELL CARCINOMA
Renpei Kato, Yoichiro Kato, Tomohiko Matsuura, Mitsugu Kanehira, Ryo
Takata, Wataru Obara. Department of Urology, Iwate Medical University
School of Medicine, Morioka, Japan
Purpose: To identify the characteristics of early-onset hematotoxicity of
sunitinib in Japanese renal cell carcinoma (RCC) patients.
Material and Methods: Seventy-nine patients were treated with sunitinib
as 6-week cycles of “4-week on 2-week off” schedule. To evaluate early-
onset hematotoxicity, we compared patients with dose reduction during
the ﬁrst cycle (dose-reduced group, n¼57) and those who maintained the
initial dose (dose-maintained group, n¼22). ABCG2 and ﬂt-3 genotypes
were analyzed for association between hematotoxicity and reported gene
polymorphisms.
Results: Mean relative dose intensity (RDI) was similar in two groups
during the ﬁrst two weeks of dosing in the ﬁrst cycle, but was signiﬁcantly
lower in dose-reduced group during the last twoweeks. Lymphocytopenia,
thrombocytopenia, and increased aspartate aminotransferase were
observed in dose-reduced group within the ﬁrst two weeks. Genetic
analysis indicated signiﬁcantly higher frequency of ﬂt-3 738T/C poly-
morphism in dose-reduced group, but no signiﬁcant difference in ABCG2
421C/A polymorphism.Conclusion: This study showed a high incidence of sunitinib-induced
hematotoxicity in Japanese RCC patients, many of whom need dose
adjustment during the ﬁrst cycle. Further studies should verify whether
dose adjustment based on early-onset thrombocytopenia prolongs suni-
tinib treatment.
IPD06:
USE OF INTRAOPERATIVE STRAIN ELASTOGRAPHY OF SMALL RENAL
MASSES TO DIFFERENTIATE BETWEEN ANGIOMYOLIPOMA AND
RENAL CELL CARCINOMA
Shohei Fukuda, Toshihiro Kanda, Naotaka Fukui, Yukio
Kageyama. Department of Urology, Saitama Cancer Center, Saitama, Japan
Purpose: Elastography is a novel ultrasound modality that evaluates tissue
stiffness. This modality has been applied for the preoperative diagnosis of
breast, liver, prostate, kidney, and thyroid cancers. In this study we
assessed the diagnostic value of intraoperative elastography in patients
with renal tumors.
Materials and Methods: This prospective study included 46 patients
(mean age 62.4 years; range 38e85 years) with a renal tumor or tumors
who underwent partial or radical nephrectomy fromMay 2014 to February
2016. Strain elastography was performed intraoperatively and strain ratios
(tumor versus normal parenchyma) were evaluated before renal artery
dissection in 46 renal tumors (mean size 41.5 mm; range 9.0e127 mm).
Histology of the resected tumors revealed clear cell renal cell carcinoma
(RCC) in 32, chromophobe RCC in 3, papillary RCC in 1, multilocular cystic
RCC in 1, invasive urothelial carcinoma (UC) in 1, oncocytoma in 1, angio-
myolipoma (AML) in 6 and leiomyoma in 1.
Results: The median tumor diameters were 41 mm (range 12e80 mm) for
clear cell RCC, 25 mm (range 18e52 mm) for chromophobe RCC, 39 mm
for papillary RCC, 18 mm for multilocular cystic RCC, 66 mm for invasive
UC, 17mm for oncocytoma, 13.5 mm (range 9.0e127 mm) for AML, and
79 mm for leiomyoma. The median strain ratios were 1.67 (range
0.37e4.75) for clear cell RCC, 1.30 (range 0.81e2.52) for chromophobe
RCC, 4.11 for papillary RCC, 2.29 for multilocular cystic RCC, 6.00 for
invasive UC, 1.85 for oncocytoma, 1.13 (range 0.30e2.29) for AML, and 1.68
for leiomyoma. For tumors smaller than 40 mm, the median strain ratio
was signiﬁcantly higher in RCCs (clear cell, chromophobe, papillary, and
multilocular cystic; n¼20) compared with AMLs (n¼5) (2.09 [range
0.37e4.11] versus 1.11 [range 0.30e1.18]) (p¼0.010). According to receiver
operating characteristic curve analysis, the optimal cut-off value for dis-
tinguishing between RCCs and AML was 1.29, with a sensitivity and
speciﬁcity of 85% and 100%, respectively. The area under the curve was
0.880.
Conclusion: Intraoperative strain elastography may be a useful modality
for differentiating between AML and RCCs in patients with renal masses
smaller than 40 mm.
IPD07:
BIOPSY FOLLOW-UP IN PATIENTS WITH ATYPICAL SMALL ACINAR
PROLIFERATION AND PROSTATE INTRAEPITHELIAL NEOPLASM IN
PROSTATE BIOPSY
Sheng-Yung Tung, Chung-Hsin Chen, Huai-Chin Tai, Sho-Mon Wang, Kuo-
How Huang, Chao-Yuan Huang, Shih-Ping Liu, Yeong-Shiau
Pu. Department of Urology, National Taiwan University Hospital, Taipei,
Taiwan
Purpose: We investigated the prognosis and outcome of atypical small
acinar proliferation (ASAP) and extensive high grade prostate intra-
epithelial neoplasm (PIN) in prostate cancer detection in Taiwan.
Materials and Methods:We retrospectively reviewed our prostate biopsy
database containing data acquired over a 20-year period in National
Taiwan University Hospital. Data collection was done by chart review. We
analyzed patient in this study period with pathology reports including
atypical glands, atypical small acinar proliferation, prostatic intraepithelial
neoplasia after receiving prostate biopsy.
Results: A total of 66 patients were enrolled. 38 patients initially had
atypical glands/ atypical small acinar proliferation; 26 patients initially
had prostatic intraepithelial neoplasia; and 2 patient had atypical small
